Montreal, QUEBEC4 Active Studies

Advanced Solid Tumors Clinical Trials in Montreal, QUEBEC

Find 4 actively recruiting advanced solid tumors clinical trials in Montreal, QUEBEC. Connect with local research sites and explore new treatment options.

4
Active Trials
4
Sponsors
885
Enrolling

Recruiting Advanced Solid Tumors Studies in Montreal

About Advanced Solid Tumors Clinical Trials in Montreal

Advanced solid tumors refer to cancers that have grown beyond the original site or spread to distant organs. Many clinical trials enroll patients with various types of advanced solid tumors to test novel therapies. These trials often investigate immunotherapy, targeted therapy, and combination approaches.

There are currently 4 advanced solid tumors clinical trials recruiting participants in Montreal, QUEBEC. These studies are seeking a combined 885 participants. Research is being sponsored by Daiichi Sankyo, Bold Therapeutics, Inc., GlaxoSmithKline and 1 other organizations. Clinical trial participation is free and participants receive study-related medical care at no cost.

Advanced Solid Tumors Clinical Trials in Montreal — FAQ

Are there advanced solid tumors clinical trials in Montreal?

Yes, there are 4 advanced solid tumors clinical trials currently recruiting in Montreal, QUEBEC. Browse the studies on this page to find one that fits.

How do I join a clinical trial in Montreal?

Browse the studies listed above, click one that interests you, and complete the free eligibility form. A study coordinator at the Montreal research site will contact you about next steps.

Are clinical trials in Montreal free?

Yes, clinical trial participation is always free. Study-related treatment, medical tests, and doctor visits are provided at no cost. Many Montreal studies also compensate for your time and travel.

What advanced solid tumors treatments are being tested?

The 4 active trials in Montreal are testing new therapies including novel drugs, biologics, and treatment approaches for advanced solid tumors.

Data updated March 2, 2026 from ClinicalTrials.gov